Search Within

Center for Hematologic Malignancies

Formats
  1. Journal Article (6192)
  2. Meeting Abstract (6164)
  3. Review (400)
  4. Book Section (216)
  5. Editorial (172)
  6. Research Letter (159)
  7. Guidelines (83)
  8. Conference Paper (70)
  9. Correspondence (61)
  10. Miscellaneous (19)
  11. Book Whole (10)
Groups
  1. Department of Medicine (11088)
  2. Hematologic Malignancies, Division of (10639)
  3. GSK Faculty (5447)
  4. Adult Leukemia (3722)
  5. Sloan Kettering Institute Faculty (3375)
  6. Hematologic Malignancies Research (3005)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (944)
  3. Ross Levine (787)
  4. Andrew Zelenetz (785)
  5. Steven Horwitz (671)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (310)
  2. 2024 (704)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3413)
  2. Journal of Clinical Oncology (869)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (304)
  5. Cancer Research (300)
  6. Haematologica (267)

More Publications

Publishers
  1. American Society of Hematology (3684)
  2. Elsevier Inc. (1668)
  3. Nature Publishing Group (1117)
  4. American Society of Clinical Oncology (918)
  5. American Association for Cancer Research (680)
  6. Wiley Blackwell (437)

More Publishers

Results (13546)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Concordance with national comprehensive cancer network (NCCN) clinical practice guidelines (CPGs): A quality of care tool for newly diagnosed patients (pts) with mantle cell lymphoma (MCL)
    Meeting Abstract

    Rodriguez, M. A.; ter Veer, A.; Nademanee, A.; Niland, J.; Lepisto, E.; Kho, M.; LaCasce, A.; Weeks, J. C.; Czuczman, M.; Millenson, M.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • Long term clinical benefit of lenalidomide (Revlimid) treatment in patients with myelodysplastic syndrome without del 5q cytogenetic abnormalities
    Meeting Abstract

    Raza, A.; Reeves, J. E.; Feldman, E. J.; Deeg, H. J.; Dreisbach, L.; Schiffer, C. A.; Shammo, J. M.; Klimek, V. M.; Greenberg, P. L.; Bennett, J. M.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • The Stanford experience with utilizing the new WHO classification of cutaneous lymphomas for cutaneous B cell lymphoma
    Meeting Abstract

    Reddy, S.; Kohler, S.; Horwitz, S.; Sutherland, K.; Hoppe, R. T.; Kim, Y. H.
    Journal of Investigative Dermatology (2006)

    Fulltext@MSK | Save
  • Treatment outcome after induction chemotherapy before allogeneic hematopoietic SCT in patients with advanced MDS
    Meeting Abstract

    Ramos, C. A.; Jakubowski, A. A.; Boulad, F.; Papadopoulos, E. B.; Young, J. W.; Kernan, N. A.; Perales, M. A.; Small, T. N.; Berman, E.; O'Reilly, R. J.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Intensity-modulated radiation therapy (IMRT) versus conventional radiotherapy using delayed accelerated concomitant boost (CBRT) for patients with locally advanced oropharyngeal carcinoma
    Meeting Abstract

    Puri, D. R.; Lee, N. Y.; De Arruda, F. F.; Wolden, S. L.; Narayana, A.; Venkatraman, E. S.; Kraus, D. H.; Shah, J. P.; Pfister, D. G.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2006)

    Fulltext@MSK | Save
  • Infectious disease associations in advanced stage, indolent lymphoma (Follicular, FL and non-follicular, nFL): Developing a lymphoma prevention strategy
    Meeting Abstract

    Portlock, C. S.; Hamlin, P. A.; Noy, A.; Palomba, M. L.; Rosenzweig, L.; Walker, D.; Corcoran, S.; Chey, W. D.; Gaydos, C. A.; Schwartz, I.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • Immunogenicity of haemophilus influenza and pneumococcal vaccines in related and unrelated transplant recipients
    Meeting Abstract

    Pao, M. K.; Papadopoulos, E. B.; Kernan, N. A.; Jakubowski, A. A.; Young, J. W.; Castro-Malaspina, H. R.; Perales, M. A.; O'Reilly, R. J.; Boulad, F.; Prockop, S.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • Pralatrexate (PDX) produces durable complete remissions in patients with chemotherapy resistant precursor and peripheral T-Cell lymphomas: Results of the MSKCC phase I/II experience
    Meeting Abstract

    O'Connor, O. A.; Hamlin, P. A.; Gerecitano, J.; Portlock, C. S.; Noy, A.; Moskowitz, C.; Straus, D. J.; Sarasohn, D.; Dumitrescu, O.; Pappanicholaou, J.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • Early phase experience with pralatrexate (10-propargyl-10-deazaaminopterin [PRX]), a novel antifolate with high affinity for the reduced folate carrier, in patients with chemotherapy refractory lymphoproliferative malignancies
    Meeting Abstract

    O'connor, O.; Hamlin, P.; Neylon, E.; Moskowitz, C.; Portlock, C.; Noy, A.; Sirotnak, F.; Zelenetz, A.; Mould, D.; Horwitz, S.
    EJC Supplements (2006)

    Fulltext@MSK | Save
  • Phase II trial of dose-dense R-CHOP followed by risk-adapted consolidation with either ICE or ICE and ASCT, based upon the results of biopsy confirmed abnormal interim restaging PET scan, improves outcome in patients with advanced stage DLBCL
    Meeting Abstract

    Moskowitz, C.; Hamlin, P. A.; Horwitz, S. M.; Noy, A.; O'Connor, O. A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; Lessac-Chenen, S.; Weaver, A.; more...
    Blood (2006)

    Fulltext@MSK | Save